Drugs / VRC-EBODNA012-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00072605 | Oct 2003 → Aug 2007 | Ebola hemorrhagic fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-EBODNA012-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00072605 ↗ |
| Modality | Vaccine | “This is a Phase I, randomized, placebo-controlled, dose-escalation study of an Ebola DNA plasmid vaccine.” NCT00072605 ↗ |
| Route | Intramuscular | “Injections are given in a muscle in the upper arm.” NCT00072605 ↗ |